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Background: Hypothalamic—pituitary—adrenal (HPA)-axis dysregulation has inconsistently been
associated with posttraumatic stress disorder (PTSD). Yet, trauma exposure rather than PTSD may
be responsible for HPA-axis dysregulation. In two meta-analyses, we assessed the association of
adulthood trauma exposure and HPA-axis functioning in healthy subjects with and without PTSD.
Method: A literature search in Pubmed and PsychInfo, using keywords and MeSH terms such as
cortisol, emotional trauma, and PTSD, was performed. Only studies that included mentally
healthy trauma-exposed (TE) individuals as well as non-exposed (NE) healthy individuals and/or
PTSD patients (PTSD) were selected. This resulted in 1511 studies of which ultimately, 37 studies
(21 TE versus NE and 34 TE versus PTSD, N = 2468) were included. Methodological quality of all
studies was assessed according to specific quality criteria. Pooled effect sizes (Hedges’s g) on
cortisol levels were compared. For all analyses, random effect models were used.
Results: Cortisol levels were neither significantly different between TE versus NE subjects
(0.029; 95%CI: 0.145; 0.088) nor between TE subjects versus PTSD patients (0.175; 95%CI:
0.012; 0.362). Subgroup analyses showed an increased cortisol suppression after the low dose
dexamethasone suppression test (DST) in TE versus NE subjects (0.509; 95%CI: 0.871; 0.148).
This meta-analysis was limited by the fact that lifetime psychiatric illness and childhood trauma
were not an exclusion criterion in all 37 studies.
Conclusion: Neither adulthood trauma exposure nor PTSD were associated with differences in
HPA-axis functioning, although adulthood trauma may augment cortisol suppression after the DST.
More evidence on other dynamic tests of HPA-axis functioning in PTSD and adulthood trauma
exposure is needed.
# 2011 Elsevier Ltd. All rights reserved.
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2 E.R. Klaassens et al.Introduction
Trauma exposure, often involving a threat to life or the
prospect of serious injury, may increase the vulnerability
to the development of many psychiatric disorders, which is
most evident in posttraumatic stress disorder (PTSD). In
patients with PTSD, neurobiological alterations of the HPA-
axis have been found. In 1986, Mason et al. were the first to
describe low urinary cortisol levels in patients with PTSD. In a
subsequent study, the same research group replicated the
results (Yehuda et al., 1990). They concluded that these
findings suggest a physiological adaptation of the HPA-axis
to chronic stress. Since then, many studies on cortisol under
basal and challenged conditions in patients with PTSD have
reported alterations in hypothalamic—pituitary—adrenal
(HPA)-axis functioning in patients with this disorder.
Several techniques are currently in use to assess HPA-axis
functioning. Cortisol is secreted with a pulsatory diurnal
rhythm, with a peak (average increase of 50%) approximately
30 min after awakening, and a progressive decline during the
day. Cortisol levels under basal conditions mainly reflect
adrenal functioning, and may be assessed in several bodily
fluids such as saliva, blood (serum or plasma) and urine.
Several challenge paradigms targeting the HPA-axis at dif-
ferent levels are also used frequently. The low dose dexa-
methasone suppression test (DST) is the most widely used
challenge test in neurobiological stress research. Ingestion of
0.5 mg of dexamethasone at 23.00 h on the night before the
test day leads to downregulation of the HPA-axis due to
feedback inhibition and induces a modest suppression of
the HPA-axis, enabling differentiation between normal,
enhanced suppression, and non-suppression. By collecting
cortisol samples before and after dexamethasone adminis-
tration, the feedback effects of dexamethasone on the HPA-
axis can be calculated. In psychiatric populations, the DSTPlease cite this article in press as: Klaassens, E.R., et al., Adulthood trau
A meta-analysis. Psychoneuroendocrinology (2011), doi:10.1016/j.psynwas first used in patients with major depressive disorder
(MDD), who showed non-suppression of cortisol in response
to dexamethasone (Carroll et al., 1976). Enhanced suppres-
sion of cortisol is reported in patients with PTSD (Yehuda
et al., 1993, 1995a, 2004b) but also in trauma-exposed
veterans without PTSD (de Kloet et al., 2007). A potentially
more sensitive measure to study negative feedback regula-
tion of the HPA-axis is the combined dexamethasone/corti-
cotropin-releasing hormone (Dex/CRH) test, originally
developed by Holsboer et al. (1987). The Dex/CRH has been
reported to differentiate between patients with MDD and
healthy controls and it has therefore been argued that the
Dex/CRH test can unveil more subtle HPA-axis disturbances.
Psychological stress challenges, such as the Trier Social Stress
Test (TSST) have also been used to study HPA-axis functioning
in relation to trauma-exposure. Most studies that used non-
pharmacological stress challenges, however, focused on
childhood trauma exposure (Heim et al., 2000; Elzinga
et al., 2003, 2008; Carpenter et al., 2007), whereas only a
few involved adulthood trauma (Liberzon et al., 1999; Brem-
ner et al., 2003).
Since Mason et al. (1986), many studies on cortisol under
basal and challenged conditions in patients with PTSD have
reported alterations in hypothalamic—pituitary—adrenal
(HPA)-axis functioning in patients with this disorder. How-
ever, the results are not consistent. Some studies reported
lower cortisol levels in PTSD patients compared to a non-
clinical sample (Rohleder et al., 2004; Neylan et al., 2005;
Yehuda et al., 2005b; Wessa et al., 2006; de Kloet et al.,
2007), whereas other studies reported higher cortisol levels
in patients with PTSD (Lindley et al., 2004; Inslicht et al.,
2006). Interestingly, military veterans with PTSD showed
lower levels of cortisol in the first hour after awakening
compared to non-trauma-exposed (NE) civilian controls.
However, compared to a control group with a history ofma and HPA-axis functioning in healthy subjects and PTSD patients:
euen.2011.07.003
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ambushed or taken hostage, seeing others being killed or
injured, and witnessing human suffering during military
operations, such as combat or peace-enforcement opera-
tions), no differences in cortisol concentrations were
reported (de Kloet et al., 2007).
There may be several explanations for the mixed results
that have been reported. First, different HPA-axis outcome
measures reflect different HPA-axis mechanisms; basal func-
tioning (Rohleder et al., 2004; Golier et al., 2006, 2007; de
Kloet et al., 2007; Gill et al., 2008; Klaassens et al., 2010a,b)
versus various dynamic tests (Yehuda et al., 2002; de Kloet
et al., 2007; Klaassens et al., 2010a,b) of HPA-axis reactivity
have been used. Second, different types of trauma (e.g.,
combat, Holocaust, other) are involved (Yehuda et al.,
1995a; Boscarino, 1996; Bonne et al., 2003; Seedat et al.,
2003; Griffin et al., 2005; Inslicht et al., 2006; Klaassens
et al., 2010a,b). Third, long term effects of early life trauma
(or early developmental stage) (Heim et al., 2000; Meinlsch-
midt and Heim, 2005; Carpenter et al., 2007; Tyrka et al.,
2008) may have a different effect on HPA-axis function in
adult life than trauma exposure during adulthood. Evidence
from studies in rodents and non-human primates have shown
that maternal separation and other trauma exposures early in
life induced persistent changes in the set-point of the HPA-
axis in such a way that there is an altered biological and
behavioural reactivity to stress in later life; these long-
lasting effects seemed stronger than upon trauma exposure
during adulthood (Sanchez et al., 2001; Tarullo and Gunnar,
2006).
Finally, in many studies healthy subjects with and without
a history of trauma exposure are brought together in a single
control group, often without making a distinction between
them (Smith et al., 1989; Lecrubier et al., 1997; Yehuda
et al., 2004a, 2007; Lindley et al., 2004; Golier et al., 2006).
Therefore, the effect, if any, of trauma exposure in the
absence of psychopathology on HPA-axis functioning, is cur-
rently unclear. The few studies that included separate
trauma-exposed (TE) and non-exposed (NE) control groups
reported conflicting results. Some studies found HPA-axis
alterations after trauma irrespective of the presence of
psychopathology (de Kloet et al., 2007; Klaassens et al.,
2009, 2010b), whereas other studies reported HPA-axis dys-
regulation after trauma only in relation to PTSD (Yehuda
et al., 2002; Griffin et al., 2005; Wessa et al., 2006).
In this paper, we present meta-analyses of studies on the
relationship between adulthood trauma, HPA-axis function-
ing and PTSD. Because the impact on HPA-axis functioning
may be different for adulthood versus childhood trauma
exposure, and because many groups of people are at risk
for trauma exposure during adulthood (e.g., military person-
nel, police officers, fire-fighters, rescue workers, health care
workers), we focussed on adulthood trauma in non-clinical
and PTSD samples. In addition, basal HPA-axis functioning as
well as dynamic tests of the HPA-axis were analyzed. We
carried out two meta-analyses: in our first meta-analysis we
examined the association of trauma exposure during adult-
hood and HPA-axis functioning in healthy subjects without
psychiatric disorders (TE) and compared them with healthy
subjects without a history of trauma exposure (NE). In our
second meta-analysis we examined whether these trauma-
exposed individuals without psychiatric disorders differedPlease cite this article in press as: Klaassens, E.R., et al., Adulthood trau
A meta-analysis. Psychoneuroendocrinology (2011), doi:10.1016/j.psynfrom PTSD patients. Our aim was to establish whether trauma
exposure during adulthood is associated with HPA-axis dys-
regulation in the absence and presence of PTSD.
Methods and materials
First, relevant studies were identified and selected according
to specific in- and exclusion criteria. After selection of the
studies, methodological quality of the studies was assessed
according to eight quality criteria.
Identification of studies
To identify relevant studies published in the English lan-
guage, a systematic computerized literature search in the
databases of PubMed and Psychinfo was performed from the
earliest available date up to January 2010. The following
(key)words and MeSH terms, including combinations, were
used: ‘post-traumatic stress disorder’, ‘PTSD’, ‘hydrocorti-
sone’, ‘cortisol’, ‘dexamethasone’, ‘HPA-axis’, ‘life change
events’, ‘psychological stress’, ‘emotional trauma’, ‘combat
disorders’, and ‘veterans’, with limitations set on ‘humans’
and ‘adults’. In addition, reference lists of the selected
articles were checked for further relevant publications, as
were reference lists of other relevant meta-analyses and
reviews (Burke et al., 2005; Otte et al., 2005; de Kloet
et al., 2006; Meewisse et al., 2007; Chida and Steptoe,
2009; Handwerger, 2009). To be selected, studies had to
include a group of TE subjects. In addition, the studies
had to assess either a group of NE controls, to facilitate
comparisons between TE and NE subjects, or a group of PTSD
patients in order to facilitate comparisons between TE sub-
jects and PTSD patients. Needless to say, studies that
assessed all three groups were included in the meta-analyses
as well. Studies that only included PTSD patients and NE
subjects were excluded. The selection process consisted of
three phases. At first, the inclusion criteria were applied to
the citations generated from the searches by the first author
(EK). During the next phase, titles identified as potentially
relevant, were requested in full text papers and closely read
by EK who also made the second selection. In the third phase,
all studies that were potentially eligible for the meta-ana-
lysis (n = 150) were assessed independently by EK, EG and/or
TV. In case of inconsistencies on a study, it was openly
discussed until consensus was reached.
In- and exclusion criteria
Only published case—control studies on humans exposed to
trauma during adulthood, written in the English language
were eligible. Studies were included when (a) the design
included a TE group as well as a NE group and/or a group of
PTSD patients; (b) the HPA-axis outcome measures were
either salivary, plasma, or 24-h urinary cortisol; (c) the
HPA-axis measurement included either basal assessment,
characteristics of the diurnal variation of cortisol, the DST,
or reactivity after the Dex/CRH test or a psychological
challenge test (Figure 1); (d) mean cortisol levels and stan-
dard deviations (SD), standard error (SE) or confidence inter-
val (CI), p-values or other statistics for the groups were
described; (e) patients had current PTSD, established withma and HPA-axis functioning in healthy subjects and PTSD patients:
euen.2011.07.003
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Figure 1 Types of HPA-axis functioning tests included in the
meta-analyses.
4 E.R. Klaassens et al.a DSM-based diagnostic interview (studies using merely a
measure of symptom severity were not included); (f) at least
two studies on the same type of HPA-axis assessment were
present; (g) TE and NE subjects were without current psy-
chiatric disorder as assessed with a DSM-III or IV (semi-
)structured interview (e.g., Structured Clinical Interview
for DSM-IV Axis I Disorders [SCID-I], Mini-International Neu-
ropsychiatric Interview [M.I.N.I.] or Composite International
Diagnostic Interview [CIDI]). Two studies (Lauc et al., 2004;
Gill et al., 2008) did only assess the absence of current PTSD
and MDD, the latter using the Clinician Administered PTSD
Scale (CAPS; Blake et al., 1995). Nonetheless, they were
included in the meta-analysis. One of these studies had an
overall quality score that was suboptimal (Lauc et al., 2004).
In case of studies fulfilling all inclusion criteria and reporting
data on overlapping cohorts, the study with the largest
sample size was included (n = 2) (Yehuda et al., 1995b; Golier
et al., 2007). When sample sizes were equal, the study with
the most complete information was included (n = 2) (Yehuda
et al., 1995a; Young and Breslau, 2004). One study (de Kloet
et al., 2008) was excluded because it was the only study that
used the Dex/CRH test to examine HPA-axis functioning in TE
subjects versus PTSD patients.
Exclusion criteria were (a) childhood trauma but not
adulthood trauma was assessed; (b) childhood trauma was
assessed in addition to adulthood trauma and some indivi-
duals only reported childhood trauma; (c) clinically signifi-
cant adrenocortical and thyroid diseases or any serious
unstable medical condition was present; (d) it was unclear
whether subjects also suffered from current PTSD.
Quality assessment
Because the HPA-axis is a delicate system that is influenced by
many factors, elimination of as many factors that are known to
potentially influence HPA-axis regulation, may well improve
the quality of studies. In addition, previous studies have shown
that the quality of studies may be improved by taking certainPlease cite this article in press as: Klaassens, E.R., et al., Adulthood trau
A meta-analysis. Psychoneuroendocrinology (2011), doi:10.1016/j.psynin- and exclusion criteria into account. Assessment of salivary
cortisol on several time points and on more than one day is
necessary to reliably assess the cortisol rise after awakening
(Hellhammer et al., 2007). Studies among recovered depres-
sives have shown that HPA-axis functioning may not return to
normal, resulting in so-called ‘scarring’ (Zobel et al., 2001;
Bhagwagar et al., 2003; Appelhof et al., 2006). In PTSD
patients who were successfully treated, an increase in plasma
cortisol levels was found after controlling for depressive
symptoms (Olff et al., 2007). Because PTSD and major depres-
sion often co-occur, we have decided to give a quality point to
studies that excluded recovered patients in their TE and NE
groups. Also, several types of psychotropic medication, espe-
cially antidepressants, may affect HPA-axis functioning
(Deuschle et al., 1997, 2003; Greden et al., 1983; Holsboer-
Trachsler et al., 1991; Manthey et al., 2011). All the factors
mentioned above were considered to be factors that improve
the methodological quality of studies on HPA-axis functioning.
The quality of the included studies was independently
assessed by two authors (EK and EG), using a checklist of 8
criteria. All quality criteria for each study were coded as
either positive or negative. A study was considered to be of
high quality when at least 5 of the following criteria were
positive: (1) HPA-axis reactivity (e.g., Dex/CRH, psychologi-
cal stress test) was assessed and/or the low dose DST was
performed; (2) multiple time points were assessed; (3) basal
cortisol was assessed on more than one day for the same
outcome measure; (4) either blood samples were collected
or, in the case of salivary cortisol sampling, extensive instruc-
tions were given or a monitoring device was used; (5) detailed
trauma assessment was carried out (6) potentially confound-
ing variables were taken into account; (7) when lifetime
psychiatric history as assessed with a DSM-III or IV (semi-
)structured interview in both the TE and NE groups was
excluded. In case only the absence of current PTSD and
MDD was assessed, we decided to include the studies as well
(n = 3); (8) use of psychotropic medication or other medica-
tion that is known to influence HPA-axis functioning was
excluded.
If a study did not report whether it met a specific quality
criterion it was coded as negative. Disagreements were
discussed until consensus was reached.
Data analysis and power calculation
Data management, calculation of effect sizes and calculation
of the pooled mean effect sizes were performed using Com-
prehensive Meta-analysis (version 2.0.021, Biostat, Engle-
wood, NJ, USA).
Two meta-analyses were conducted; one for the TE sub-
jects versus the NE control subjects, and one for the TE
subjects versus the PTSD patients. Effect sizes were calcu-
lated for three types of outcome data: (1) mean cortisol
differences between the study groups (TE vs. NE and TE vs.
PTSD), (2) the difference between the study groups percen-
tage cortisol suppression to the DST, and (3) the Area Under
the Curve with respect to ground (AUCg) of the cortisol levels
after the Dex/CRH test. The AUCg, is a composite measure
calculated according to the trapezoidal method (Pruessner
et al., 2003). In the overall meta-analyses, the effect sizes
for the DST (n = 5 for the TE versus NE groups and n = 9 for thema and HPA-axis functioning in healthy subjects and PTSD patients:
euen.2011.07.003
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Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: A meta-analysis 5TE versus PTSD patients group) and Dex/CRH test (n = 2 for
the TE versus NE groups) were analyzed separately, because
the interpretation of dynamic tests is different from basal
conditions. These outcome measures were assessed in sub-
group analyses only. Hedges’s g (Hedges, 1982) weighted
effect size was used as metric for all mean comparison.
Hedges’s g adjusts for differences in (small) sample sizes
and yields a more conservative metric than Cohen’s d (Deeks
et al., 2009). All analyses were performed with the random-
effects model. To assess heterogeneity between the studies
we calculated the I2, which is an indicator of heterogeneity in
percentages. A zero percent (0%) value means no observed
heterogeneity, and higher values represent increasing het-
erogeneity. Generally heterogeneity is categorised in 25%
(low), 50% (moderate) and 75% (high) (Higgins et al.,
2003). In addition, Q-statistics were calculated. A statisti-
cally significant Q rejects the null hypothesis of homogeneity
and indicates a heterogeneous distribution of effect sizes
between studies, meaning that systematic differences are
present, and may influence the results.
The presence of publication bias was assessed by inspect-
ing the funnel plot on primary outcome measures (effects on
cortisol levels) and by Duval and Tweedie’s trim and fill
procedure (Duval and Tweedie, 2000) as implemented in
the CMA software. This procedure yields an estimate of
the effect size after publication bias has been taken into
account, by calculating adjusted values of the pooled mean
effect sizes and 95% confidence intervals. In this procedure,
random effects models were used.
Power calculation
As proposed by Lipsey (1990), effect sizes of 0.3 were con-
sidered to be small. To investigate if there was sufficient
statistical power in our meta-analysis to detect a small effect
size, we conducted a power calculation according to the
procedures described by Borenstein et al. (2009). These cal-
culations indicated that we would need to include at least 14
studies with a mean sample size of 50 (25 participants per
condition), to be able to detect an effect size of Hedges’s
g = 0.30 (conservatively assuming a high level of between-
study variance, a statistical power of 0.80, and a significance
level, alpha, of 0.05). Alternatively, we would need 18 studies
with 40 participants each to detect an effect size of Hedges’s
g = 0.30, or 24 studies with 30 participants. As we included 21
studies for the TE group (median of 16 participants, range 5—
265) versus the NE group (median of 15 participants, range 8—
183) and 34 studies for the TE group (median of 15, range 5—
265) versus the PTSD group (median of 21 participants, range
7—75), our analyses were sufficiently powered.
A post hoc power calculation showed that the 21 studies
comparing non-exposed with trauma-exposed subjects had
sufficient power to detect a significant effect size of 0.16,
and the 34 studies comparing PTSD with trauma-exposed
subject had sufficient power to detect a significant effect size
of 0.15.
Subgroup analysis
For each subgroup, the pooled mean effect size was calcu-
lated, and a test was conducted to examine putative differ-Please cite this article in press as: Klaassens, E.R., et al., Adulthood trau
A meta-analysis. Psychoneuroendocrinology (2011), doi:10.1016/j.psynences in effect sizes. Subgroup analyses were conducted for
the following characteristics: HPA-axis outcome measure,
type of trauma, gender, age groups, and quality of the




The literature search combining the key words and MeSH
terms resulted in 1511 studies (Supplement 1). After the first
screening of abstracts and methods sections to select studies
with a TE group, an NE control group and/or a group of PTSD
patients, cortisol as an outcome measure and one of the five
ways to assess HPA-axis functioning (Fig. 1), 150 studies were
left. These studies were requested in full-text and screened
in more detail by two raters (EK and EG or TV) independently.
Thirty-nine of these 150 studies were discussed in detail to
reach consensus about in- or exclusion. After this second
screening, another 111 studies were excluded, leaving 39
studies eligible for our meta-analyses. The main reasons for
exclusion in this phase were (1) no TE group was present
(n = 45); (2) childhood trauma and not adult trauma exposure
was assessed (n = 20); and (3) neither a PTSD patient group or
a NE control group was studied (n = 14) (S1). From the
corresponding authors of 10 studies we requested additional
information on cortisol levels and on the exclusion of (child-
hood) trauma exposure. From seven of these (Lauc et al.,
2004; Pico-Alfonso et al., 2004; Rohleder et al., 2004; Olff
et al., 2006; Wessa et al., 2006; Simeon et al., 2008; Johnson
et al., 2008), we received the requested data and the studies
were included in the meta-analyses. Unfortunately, three
authors did not respond to our request (Boscarino, 1996;
Kanter et al., 2001; Neylan et al., 2003b). As a result, two of
these studies were not included, whereas for one study we
could only include basal cortisol data (Neylan et al., 2003b).
Study characteristics
The characteristics of the 37 included studies are outlined in
Supplement 2. A total of 2468 subjects were included (1120
TE subjects, 508 NE controls, and 840 PTSD patients). The
majority of the studies (n = 18) included a TE, an NE and a
PTSD group. In an additional 17 studies only TE subjects and
PTSD patients were examined, and three studies compared
TE subjects and NE controls exclusively. As a result, the meta-
analysis comparing TE subjects with NE control subjects
included 21 studies, whereas the meta-analysis of TE sub-
jects and PTSD patients included 34 studies. The majority of
the studies included adult subjects (18—65 years of age),
whereas three studies included older adults. Twelve studies
included military personnel with combat exposure and seven
studies included individuals with exposure to the Holocaust
(Yehuda et al., 1995b, 2005a,b, 2009), war (Rohleder et al.,
2004; Roth et al., 2006) or genocide (Eckart et al., 2009). One
study included both combat veterans and Holocaust survivors
(Yehuda et al., 2002). One study included both combat
veterans and individuals exposed to various civilian trauma
(Yehuda et al., 2004b). Five studies included women with a
history of violence by an intimate partner (Seedat et al.,ma and HPA-axis functioning in healthy subjects and PTSD patients:
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6 E.R. Klaassens et al.2003; Pico-Alfonso et al., 2004; Griffin et al., 2005; Inslicht
et al., 2006; Johnson et al., 2008) and 14 studies assessed
individuals with other types of trauma (e.g., motor vehicle
accidents, assault, disaster).
Thirty studies assessed basal cortisol; for this, 19 used
salivary samples, six studies used plasma cortisol samples,
and five studies assessed 24-h urinary cortisol (Pitman and
Orr, 1990; Yehuda et al., 1995b, 2009; Bierer et al., 2006;
Simeon et al., 2008). Three studies assessed basal cortisol at
two time points over the day (Pico-Alfonso et al., 2004; Young
and Breslau, 2004; Gill et al., 2008) and seven studies
assessed salivary cortisol at multiple time points (Young
et al., 2004; Yehuda et al., 2005a,b; Inslicht et al., 2006;
Lindauer et al., 2006; Roth et al., 2006; Eckart et al., 2009).
From one study we were only able to use an AM salivary
cortisol sample because additional information was not avail-
able (Neylan et al., 2003b). Of the studies of salivary cortisol,
eight calculated the salivary cortisol response to awakening
(CAR) (Lauc et al., 2004; Rohleder et al., 2004; Olff et al.,
2006; Wessa et al., 2006; de Kloet et al., 2007; Johnson et al.,
2008; Klaassens et al., 2010a,b). Of the seven studies of
plasma cortisol, six sampled at one time point (Yehuda et al.,
2002; Bonne et al., 2003; Neylan et al., 2003a; Seedat et al.,
2003; Liberzon et al., 2007; Shalev et al., 2008) and one study
collected 24-h plasma cortisol (Golier et al., 2007).
Nine studies used the low dose dexamethasone suppression
test (DST) (Yehuda et al., 1995a, 2002, 2004b; Bachmann
et al., 2005; Griffin et al., 2005; Golier et al., 2006; de Kloet
et al., 2007; Metzger et al., 2008; Simeon et al., 2008) of which
seven assessed plasma cortisol (Yehuda et al., 1995a, 2002,
2004b; Bachmann et al., 2005; Griffin et al., 2005; Golier
et al., 2006; Simeon et al., 2008), one study assessed salivary
cortisol (Metzger et al., 2008), and one study assessed cortisol
suppression after dexamethasone both in salivary and in
plasma cortisol (de Kloet et al., 2007). The majority of these
studies assessed pre- and post-Dex cortisol in morning samples,
whereas two studies used afternoon samples (Yehuda et al.,
1995a; de Kloet et al., 2007). Two studies that assessed HPA-
axis functioning with the DST also assessed the CAR (de Kloet
et al., 2007; Simeon et al., 2008). Two studies assessed plasma
cortisol levels after the Dex/CRH challenge test in addition to
the CAR (Klaassens et al., 2010a,b).
Two of the 37 studies met all 8 quality criteria (Klaassens
et al., 2010a,b), 14 studies (38%) were considered of good
quality (i.e., meeting five or more criteria). All 37 studies
met the criterion for detailed trauma assessment. Only four
studies sampled basal cortisol on more than one day (Pico-
Alfonso et al., 2004; Rohleder et al., 2004; Klaassens et al.,
2010a,b). Of the 19 studies that sampled salivary cortisol, 14
gave extensive sampling instructions in order to increase
compliance (Lauc et al., 2004; Pico-Alfonso et al., 2004;
Young et al., 2004; Young and Breslau, 2004; Lindauer
et al., 2006; Roth et al., 2006; Wessa et al., 2006; de Kloet
et al., 2007; Gill et al., 2008; Johnson et al., 2008; Metzger
et al., 2008; Eckart et al., 2009; Klaassens et al., 2010a,b).
None of the studies used time-monitoring devices. Twenty-
five studies checked for potential confounders (Yehuda et al.,
2005a), adjusted for potential confounders (Yehuda et al.,
2002, 2004b, 2005b, 2009; Bonne et al., 2003; Neylan et al.,
2003b; Pico-Alfonso et al., 2004; Rohleder et al., 2004; Young
et al., 2004; Young and Breslau, 2004; Griffin et al., 2005;
Golier et al., 2006, 2007; Inslicht et al., 2006; Olff et al.,Please cite this article in press as: Klaassens, E.R., et al., Adulthood trau
A meta-analysis. Psychoneuroendocrinology (2011), doi:10.1016/j.psyn2006; Wessa et al., 2006; de Kloet et al., 2007; Shalev et al.,
2008; Gill et al., 2008; Johnson et al., 2008; Metzger et al.,
2008; Klaassens et al., 2010a,b) or excluded participants on
potentially confounding variables such as smoking (Eckart
et al., 2009). Of the 37 included studies, 19 excluded all
psychotropic medication, seven did not mention medication
use (Neylan et al., 2003b; Lauc et al., 2004; Young et al.,
2004; Bierer et al., 2006; Roth et al., 2006; Shalev et al.,
2008; Metzger et al., 2008). Lifetime psychiatric disorders
were excluded in TE and/or NE subjects in ten studies
(Yehuda et al., 1995b, 2005a, 2009; Bonne et al., 2003;
Neylan et al., 2003a; Seedat et al., 2003; Rohleder et al.,
2004; Olff et al., 2006; Klaassens et al., 2010a,b), whereas
the other 27 studies did not exclude lifetime psychiatric
disorders in their TE subjects or NE controls or did not report
this.
Most quality points were lost by not assessing HPA-axis
functioning on more than one day and by not excluding
subjects with a history of psychiatric disorders in the control
groups. When we considered the quality of studies regardless
of assessment on one or more days, 10 studies were of less
than optimal quality. Overall, the quality of HPA-axis assess-
ment was good to excellent, most studies adjusted their
findings for confounders and all described detailed assess-
ment of trauma exposure during adulthood. This made us
decide to include these 37 studies in our meta-analyses. The
median quality score of studies assessing basal cortisol levels
was 4 and the median quality score of studies assessing HPA-
axis reactivity with the DST was 5 and for the two studies
using the Dex/CRH test (Klaassens et al., 2010a,b) the med-
ian score was 8 points.
TE subjects versus NE control subjects
Fig. 2a shows a forest plot of the effect sizes (Hedges’s g) of
cortisol levels in TE subjects relative to NE controls subjects
in each of the 20 studies. The pooled effect size (Hedges’s g)
using the random-effects model was 0.029 (95%CI: 0.145;
0.088), which suggests no difference in basal cortisol levels
between TE subjects and NE controls with adult trauma-
exposure. The overall analysis was performed without the
DST and Dex/CRH outcomes. There was no heterogeneity
(I2 = 0.00%, p = 0.468) in results between studies (Table 1a).
TE subjects versus PTSD patients
Fig. 2b shows a forest plot of the effect sizes (Hedges’s g) of
cortisol levels in TE subjects relative to patients with PTSD in
each of the 34 studies. The overall analysis was performed
without the DSToutcome. There was significant heterogeneity
(I2 = 68.26%, p < 0.001) in results between studies. The pooled
effect size (Hedges’s g) using the random-effects model was
0.175 (95%CI: 0.012; 0.362), which suggests no difference in
HPA axis functioning between TE subjects and PTSD patients
with adulthood trauma exposure (Table 1b).
Subgroup analyses
All subgroup analyses were performed separately for the TE
versus the NE subjects and for the TE subjects versus the
PTSD patients.ma and HPA-axis functioning in healthy subjects and PTSD patients:
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Yeh uda  200 2 10 9 -0. 457 -1. 329 0.41 5 -1.0 27 0.30 4
Yeh uda  200 4 9 9 -0. 242 -1. 126 0.64 1 -0.5 38 0.59 1
77 76 -0. 509 -0. 871 -0. 148 -2.7 62 0.00 6
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Figure 2 (a) Hedges’s pooled effect sizes (with 95% confidence interval) of cortisol levels between trauma-exposed and non-trauma
exposed individuals without psychiatric disorders (n = 20 studies). Pooled estimate based on random-effects model. (b) Hedges’s
pooled effect sizes (with 95% confidence interval) of cortisol levels between trauma-exposed individuals without psychiatric disorders
and PTSD patients (n = 34 studies). Pooled estimate based on random-effects model.
Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: A meta-analysis 7In the subgroup analyses for HPA-axis outcome measure,
we performed subgroup analyses for the different basal
measures of cortisol (i.e., saliva, blood, and urine) as well
as for the dynamic cortisol measures (DST and Dex/CRH). No
differences were found in the basal outcome measures or in
the Dex/CRH cortisol levels. However, in the subgroup ana-
lysis on cortisol suppression after the low dose DST, a stronger
cortisol suppression in TE subjects (Hedges’s g = 0.509,
p = 0.006) relative to NE subjects was found (Table 1a).
The pooled effect size for the DST, however, was not statis-
tically significant when comparing TE subjects with PTSD
patients (Table 1b).
The pooled Hedges’s g, did not differ according to age,
gender, type of trauma, lifetime psychiatric disorders in TE
and/or NE subjects, and medication use or comorbid MDD inPlease cite this article in press as: Klaassens, E.R., et al., Adulthood trau
A meta-analysis. Psychoneuroendocrinology (2011), doi:10.1016/j.psynPTSD patients, neither for TE subjects compared to NE con-
trols nor for TE subjects compared to PTSD patients. When in
sensitivity analyses the higher quality studies only were
combined, the results remained similar. In detail, the 10
high-quality studies that compared TE versus NE yielded a
Hedges’s g of 0.101 and the 11 high-quality studies that
compared TE versus PTSD yielded a Hedges’s g of 0.169, that
were largely of strengths similar to the overall effect sizes of
0.029 and 0.175, respectively (Tables 1a and 1b).
A post hoc sensitivity analysis in the TE versus PTSD groups
revealed that the 5 studies with Holocaust victims showed
the largest effect size that approached statistical signifi-
cance (Hedges’s g 0.446, p = 0.084), followed by the 18
studies that included other forms of trauma (Hedges’s g
0.237, p = 0.077), while no hint for an effect was found inma and HPA-axis functioning in healthy subjects and PTSD patients:
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Figure 2. (Continued ).
8 E.R. Klaassens et al.studies on trauma experienced during combat (Hedges’s g
0.044, p = 0.770; Table 1b).
There were no significant interactions between, on the
one hand, TE versus NE and TE versus PTSD, and, on the other
hand, subgroups (all ps > 0.20 for interaction). In other
words, subgroups did not significantly differ for their effect
sizes, in none of the meta-analyses.
In the two main analyses, neither the funnel plot nor Duval
and Tweedie’s trim and fill procedure pointed at a significant
publication bias (data not shown). The effect sizes did not
change after adjustment for possible publication bias in both
analyses (the observed and adjusted effect sizes werePlease cite this article in press as: Klaassens, E.R., et al., Adulthood trau
A meta-analysis. Psychoneuroendocrinology (2011), doi:10.1016/j.psynexactly the same, and the number of imputed studies was
zero).
Discussion
Our main finding is that TE individuals in the absence of
psychopathology did not differ on basal cortisol levels from
NE healthy control subjects. Moreover, PTSD patients did not
differ from TE subjects with respect to basal cortisol levels.
Results were largely consistent for saliva, plasma and urine in





























































































































Hedges’s g 95%CI p-Value for
effect size
Z Q I 2 p-Value for
heterogeneity
Trauma-exposed (TE) and non-exposed (NE) healthy subjects
All studies (without
DST and Dex/CRH)
21 710/513 0.029 0.146; 0.087 0.620 0.495 19.636 0.00 0.481
Outcome
Salivary cortisol 11 585/382 0.023 0.156; 0.109 0.730 0.346 9.852 0.00 0.454
Plasma cortisol 9 162/120 0.089 0.345; 0.168 0.498 0.678 8.581 6.77 0.397
Urinary cortisol 3 49/37 0.001 0.567; 0.570 0.997 0.004 3.521 43.20 0.172
DST 6 76/77 0.482 0.862; 0.102 0.013 2.484 6.901 27.55 0.228
Dex/CRH test 2 75/46 0.048 0.315; 0.411 0.796 0.258 0.492 0.00 0.483
Type of trauma
Combat 5 93/92 0.077 0.363; 0.209 0.599 0.526 3.732 0.00 0.444
Holocaust 5 79/90 0.117 0.185; 0.419 0.447 0.761 1.309 0.00 0.860
Other 11 538/331 0.085 0.285; 0.115 0.405 0.832 13.504 25.95 0.197
Gender
Male 5 120/100 0.146 0.436; 0.144 0.324 0.986 4.723 15.23 0.317
Female 5 188/82 0.001 0.408; 0.410 0.998 0.003 8.229 51.39 0.084
Age
40 years 8 413/288 0.097 0.310; 0.116 0.374 0.889 8.563 18.26 0.286
>40 years 13 297/225 0.007 0.172; 0.185 0.942 0.072 10.801 0.00 0.546
Quality
High 10 299/171 0.101 0.330; 0.128 0.388 0.863 11.685 22.98 0.232
Suboptimal 11 411/342 0.005 0.138; 0.149 0.941 0.074 7.302 0.00 0.697
Note: HPA-axis, hypothalamus—pituitary—adrenal-axis; TE, trauma exposed healthy subjects; NE, non-exposed healthy subjects; 95%CI indicates 95% confidence interval; DST, dexamethasone









































































































































































Hedges’s g 95%CI p-Value for
effect size
Z Q I 2 p-Value for
heterogeneity
Trauma-exposed (TE) healthy subjects and PTSD patients (PTSD)
All studies (without DST) 34 967/835 0.177 0.011; 0.365 0.065 1.846 104.842 68.52 0.000
Outcome
Salivary cortisol 17 621/458 0.155 0.061; 0.372 0.160 1.405 39.217 59.20 0.001
Plasma cortisol 14 307/299 0.102 0.188; 0.393 0.491 0.689 33.752 61.48 0.001
Urinary cortisol 5 74/109 0.162 0.816; 1.139 0.746 0.325 36.213 89.95 0.000
DST 9 166/236 0.009 0.272; 0.255 0.949 0.064 12.144 34.12 0.145
Type of trauma
Combat 11 210/269 0.044 0.343; 0.254 0.770 0.292 24.806 59.69 0.006
Holocaust 5 79/120 0.446 0.060; 0.952 0.084 1.726 11.561 65.40 0.021
Other 18 678/446 0.237 0.026; 0.499 0.077 1.768 11.561 65.40 0.021
Gender
Male 10 169/226 0.034 0.377; 0.310 0.847 0.192 24.588 63.40 0.003
Female 7 197/177 0.341 0.222; 0.904 0.235 1.188 37.475 83.99 0.000
Age
40 years 13 538/274 0.103 0.166; 0.372 0.452 0.752 28.499 57.89 0.005
>40 years 21 429/561 0.220 0.042; 0.483 0.100 1.645 75.578 73.54 0.000
Quality
High 11 227/221 0.169 0.235; 0.573 0.412 0.820 39.468 74.66 0.000
Suboptimal 22 731/586 0.169 0.051; 0.389 0.133 1.504 64.152 67.27 0.000
Note:HPA-axis, hypothalamus—pituitary—adrenal-axis; TE, trauma exposed subjects; PTSD, posttraumatic stress disorder patients; 95%CI indicates 95% confidence interval; DST, dexamethasone














PNEC-2017; No. of Pages 15
Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: A meta-analysis 11ence concerned DST findings, as adulthood trauma may aug-
ment cortisol suppression after the DST. As mentioned earlier,
in trauma-exposed veterans without PTSD enhanced suppres-
sion of cortisol is reported (de Kloet et al., 2007). This is in
line with pre-clinical studies that showed long-term altera-
tion in glucocorticoid regulation in response to an acute or
chronic stressor (van Dijken et al., 1993; Buwalda et al.,
1999). Increased sensitivity of the HPA-axis to corticosteroids
after trauma exposure may be a mechanism of the body to
protect itself against the detrimental effects of sustained
high cortisol levels.
In contrast to exposure to childhood trauma, which is
associated with alterations in HPA-axis functioning (Heim
et al., 2000; Rinne et al., 2002; Meinlschmidt and Heim,
2005; Carpenter et al., 2007; Tyrka et al., 2008; Klaassens
et al., 2009), trauma during adulthood was not associated
with basal cortisol. This is also in line with our post hoc
sensitivity analysis in which we excluded Holocaust studies,
which markedly attenuated the effect size. This seems valid
as trauma exposure during the Holocaust very likely also
included trauma exposure during childhood. At least some
of the Holocaust survivors that were included were likely to
be under 16 years of age when they were subjected to a life in
a concentration camp, ghetto or in hiding, and therefore the
tendency for a stronger effect size may have been due to the
fact that part of the subjects were exposed to trauma during
childhood rather than adulthood.’’
Our main finding of a lack of association, is also in line with a
subgroup analysis from the meta-analysis of Meewisse et al.
(2007) on basal cortisol in adult subjects with and without
PTSD, as they found no differences between people with PTSD
and TE controls. In our meta-analysis, however, we extended
the analysis from 15 studies that were included in their meta-
analysis (Meewisse et al., 2007) to 34 studies in ours. Moreover,
we exclusively focussed on adulthood trauma, whereas the
other meta-analysis also included studies on victims of child-
hood sexual and physical abuse. Thus, our meta-analysis lends
support for the hypothesis that adulthood trauma does not
(markedly) affect HPA-axis functioning.
We included the dynamic DST and the Dex/CRH test in our
meta-analyses, contrary to the former meta-analysis (Mee-
wisse et al., 2007). Our analysis suggested that studies using
the DST found more cortisol suppression in TE subjects
compared with NE controls. Trauma-exposure during adult-
hood may thus be associated with a stronger HPA-axis feed-
back response. This suggests that the often-reported
association between PTSD and negative feedback systems
of cortisol could be trauma-related. Our second meta-ana-
lysis, however, did not extend this finding to PTSD subjects;
no differences in effect size on the DST were found between
TE subjects and PTSD patients. Differences in HPA-axis func-
tioning between these groups have been ascribed to the
presence of PTSD. In light of our findings, however, DST
differences could be associated with trauma exposure rather
than with PTSD psychopathology. Yet, the findings on the DST
in TE versus NE subjects, were based on only 5 studies, and
should be interpreted cautiously. Based on only two studies,
no association was found between trauma exposure in adult-
hood and HPA-axis functioning during the Dex/CRH challenge
test (Klaassens et al., 2010a,b).
There are several possible explanations for the inconsis-
tent findings in previous studies when comparing PTSDPlease cite this article in press as: Klaassens, E.R., et al., Adulthood trau
A meta-analysis. Psychoneuroendocrinology (2011), doi:10.1016/j.psynpatients to NE participants. First, the PTSD group may con-
sist of a heterogeneous patient groups, as different forms of
adult trauma (e.g., sexual violence/abuse, combat, Holo-
caust) were studied in different publications. Second, non-
linear associations with cortisol could exist that was not
investigated with the techniques used in our meta-analysis.
Recent publications showed both hypo- and hyperactivity of
the HPA-axis being associated with depression (Bremmer
et al., 2007; Penninx et al., 2011) or its dimensions in
subjects with and without anxiety and depressive disorders
(Wardenaar et al., 2011), which might also be present in
PTSD. Third, publication bias may play a role, even if no true
difference is present between the two groups. Studies find-
ing either significantly enhanced or diminished cortisol
levels in PTSD (Type 1 errors) may have higher chances to
be published than studies that showed non-significant
results. This may also explain the larger heterogeneity
between study results when comparing TE versus PTSD sub-
jects.’’
Limitations and strengths
The results of this meta-analysis should be interpreted in
light of the limitations of the analyses and the body of studies
within it. First, despite our efforts to include all available
studies and good agreement between the reviewing authors,
we cannot rule out the possibility that we have missed some
studies meeting the inclusion criteria and we could not
calculate inter-rater reliability scores for double-screening
scores from pairs of reviewing authors. Fortunately, publica-
tion bias analyses suggest that, although some studies may
have been missed, publication bias is unlikely to have influ-
enced our findings. Second, in the process of designing these
meta-analyses, several decisions based on our in- and exclu-
sion criteria were made. Different criteria might have led to
slightly different results. Third, we have included studies
that did not specifically mention the assessment of childhood
trauma exposure. We have taken the shortcoming of these
studies into account in the quality score, which was used to
do a sensitivity analysis only in studies of higher quality
(Tables 1a and 1b). Fourth, not all studies explicitly stated
whether they assessed lifetime psychiatric illness using
(semi-)structured interviews, and therefore may have
included subjects with past diagnoses of, e.g., adjustment
disorders, mood disorders, and acute stress disorder. Fifth,
some of the included studies had very small sample sizes,
mostly as a result of the fact that the two control groups (TE
and NE) were initially recruited as one control group and
subgroup analyses were later performed. Finally, the quality
of most studies (59%) was not optimal. Some studies assessed
only one basal sample of cortisol, which in most cases was not
related to time of awakening. The cortisol level assessed with
a single time-point sample is very easily influenced by stress
(e.g., in case of a vena puncture) or daytime variability. A
strength of our meta-analysis was that we did not only
include studies on basal cortisol sampling but also studies
of cortisol reactivity to the DST and the Dex/CRH challenge
test. In doing so, we have tried to create a more complete
picture of HPA-axis functioning in relation to exposure to
adulthood trauma in subjects with and without psychiatric
disorders.ma and HPA-axis functioning in healthy subjects and PTSD patients:
euen.2011.07.003
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The lack of difference in pooled effect size between subjects
with and without adult trauma exposure suggests that trauma
exposure during adulthood per se is unlikely to affect basal
HPA-axis functioning in subjects without PTSD. In addition, no
evidence was found for an association of PTSD with basal HPA-
axis functioning. Moreover, the lack of heterogeneity for the
first meta-analysis suggests that additional studies on trauma
exposure during adulthood are unlikely to yield different
results. Interestingly, in a subgroup analysis of 5 studies
we found that in the DST there was more cortisol suppression
in TE subjects than in NE controls.
There are some (clinical) implications of our findings. Since
there seems to be an interaction between trauma exposure,
HPA-axis regulation and stress-related disorders such as PTSD,
this may help us understand why some people do and others do
not develop psychiatric disorders in the aftermath of traumatic
stress. Moreover, the enhanced suppression after the DST may
be contributing to an increased vulnerability to further expo-
sure to stressors in the trauma-exposed subjects. Neverthe-
less, as we did not find large differences in basal cortisol levels
among the groups, we advice further studies in this field to
focus on more sensitive dynamic tests of HPA-axis integrity. In
future studies on the effects of trauma, not only in patients
with PTSD but also in patients with other psychiatric disorders,
we therefore propose to carefully differentiate between adult-
hood and childhood trauma. Moreover, as most data is present
for basal cortisol and the low-dose DST, more evidence on other
dynamic tests of HPA-axis functioning in PTSD and adulthood
trauma exposure is needed (e.g., de Kloet et al., 2008).
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